Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 138Prostatic Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 10Motor Activity 8Ovarian Neoplasms 7Gastrointestinal Neoplasms 7Neoplasms 5Uterine Cervical Neoplasms 4Sarcoma 4Lymphoma 4Endometrial Neoplasms 4Depression 4Pain 3Hereditary Breast and Ovarian Cancer Syndrome 3Fatigue 3Colonic Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Anxiety Disorders 3Vomiting 2Thyroid Neoplasms 2Neoplasm Metastasis 2Melanoma 2Leukemia 2Hodgkin Disease 2Head and Neck Neoplasms 2Communication 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Carcinoma In Situ 2

Interventions

Surveys and Questionnaires 2Exercise 2Transcranial Direct Current Stimulation 1Restraint, Physical 1Qigong 1Control Groups 1Apolipoproteins E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Cancer Survivors × Surveys and Questionnaires × Breast × Clear all
NCT02726763 2026-04-27

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
18 enrolled
Breast

Breast Cancer Survivors

NCT02753985 2019-07-23

Adherence to Aromatase Inhibitors: The Role of Partners

Abramson Cancer Center at Penn Medicine

Completed
40 enrolled
Breast

Breast Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡